Logo image of LION

LIONSGATE STUDIOS CORP (LION) Stock Fundamental Analysis

USA - NYSE:LION - CA53626N1024 - Common Stock

6.64 USD
-0.02 (-0.3%)
Last: 11/14/2025, 8:04:00 PM
6.79 USD
+0.15 (+2.26%)
After Hours: 11/14/2025, 8:04:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LION. LION was compared to 79 industry peers in the Entertainment industry. Both the profitability and financial health of LION have multiple concerns. LION does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LION had negative earnings in the past year.
LION had a negative operating cash flow in the past year.
In multiple years LION reported negative net income over the last 5 years.
LION had a negative operating cash flow in each of the past 5 years.
LION Yearly Net Income VS EBIT VS OCF VS FCFLION Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

The Return On Assets of LION (-2.70%) is comparable to the rest of the industry.
LION's Return On Invested Capital of 4.15% is fine compared to the rest of the industry. LION outperforms 72.15% of its industry peers.
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROIC 4.15%
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LION Yearly ROA, ROE, ROICLION Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

With a decent Operating Margin value of 5.41%, LION is doing good in the industry, outperforming 67.09% of the companies in the same industry.
LION's Gross Margin of 117.71% is amongst the best of the industry. LION outperforms 100.00% of its industry peers.
Industry RankSector Rank
OM 5.41%
PM (TTM) N/A
GM 117.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LION Yearly Profit, Operating, Gross MarginsLION Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

0

2. Health

2.1 Basic Checks

LION has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LION Yearly Shares OutstandingLION Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
LION Yearly Total Debt VS Total AssetsLION Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LION has an Altman-Z score of -0.19. This is a bad value and indicates that LION is not financially healthy and even has some risk of bankruptcy.
LION's Altman-Z score of -0.19 is on the low side compared to the rest of the industry. LION is outperformed by 67.09% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.19
ROIC/WACCN/A
WACCN/A
LION Yearly LT Debt VS Equity VS FCFLION Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

LION has a Current Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
LION has a worse Current ratio (0.36) than 87.34% of its industry peers.
LION has a Quick Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
LION has a worse Quick ratio (0.36) than 86.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
LION Yearly Current Assets VS Current LiabilitesLION Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.48%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.32%

3.2 Future

LION is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.82% yearly.
The Revenue is expected to grow by 1.79% on average over the next years.
EPS Next Y-220.55%
EPS Next 2Y71.99%
EPS Next 3Y50.63%
EPS Next 5Y25.82%
Revenue Next Year-14.66%
Revenue Next 2Y1.47%
Revenue Next 3Y1.79%
Revenue Next 5YN/A

3.3 Evolution

LION Yearly Revenue VS EstimatesLION Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 1B 2B 3B 4B
LION Yearly EPS VS EstimatesLION Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LION. In the last year negative earnings were reported.
LION is valuated rather expensively with a Price/Forward Earnings ratio of 20.41.
Based on the Price/Forward Earnings ratio, LION is valued cheaper than 81.01% of the companies in the same industry.
LION's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.59.
Industry RankSector Rank
PE N/A
Fwd PE 20.41
LION Price Earnings VS Forward Price EarningsLION Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

91.14% of the companies in the same industry are more expensive than LION, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.79
LION Per share dataLION EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

A more expensive valuation may be justified as LION's earnings are expected to grow with 50.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.99%
EPS Next 3Y50.63%

0

5. Dividend

5.1 Amount

No dividends for LION!.
Industry RankSector Rank
Dividend Yield N/A

LIONSGATE STUDIOS CORP

NYSE:LION (11/14/2025, 8:04:00 PM)

After market: 6.79 +0.15 (+2.26%)

6.64

-0.02 (-0.3%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-04 2026-02-04
Inst Owners69.3%
Inst Owner Change6.67%
Ins Owners3.69%
Ins Owner Change9.61%
Market Cap1.92B
Revenue(TTM)N/A
Net Income(TTM)-145.34M
Analysts81.18
Price Target8.78 (32.23%)
Short Float %7.26%
Short Ratio5.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)303.17%
Min EPS beat(2)-20.6%
Max EPS beat(2)626.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.44%
Max Revenue beat(2)3.22%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.41
P/S 0.9
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.79
EPS(TTM)-0.09
EYN/A
EPS(NY)0.33
Fwd EY4.9%
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS7.34
BVpS-3.73
TBVpS-15.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROCE 5.25%
ROIC 4.15%
ROICexc 4.53%
ROICexgc N/A
OM 5.41%
PM (TTM) N/A
GM 117.71%
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.48
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.19
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)0.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.48%
EPS Next Y-220.55%
EPS Next 2Y71.99%
EPS Next 3Y50.63%
EPS Next 5Y25.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.32%
Revenue Next Year-14.66%
Revenue Next 2Y1.47%
Revenue Next 3Y1.79%
Revenue Next 5YN/A
EBIT growth 1Y331.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.85%
EBIT Next 3Y34.12%
EBIT Next 5Y24.75%
FCF growth 1Y-72843.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70899.5%
OCF growth 3YN/A
OCF growth 5YN/A

LIONSGATE STUDIOS CORP / LION FAQ

What is the fundamental rating for LION stock?

ChartMill assigns a fundamental rating of 1 / 10 to LION.


Can you provide the valuation status for LIONSGATE STUDIOS CORP?

ChartMill assigns a valuation rating of 3 / 10 to LIONSGATE STUDIOS CORP (LION). This can be considered as Overvalued.


Can you provide the profitability details for LIONSGATE STUDIOS CORP?

LIONSGATE STUDIOS CORP (LION) has a profitability rating of 2 / 10.


Can you provide the financial health for LION stock?

The financial health rating of LIONSGATE STUDIOS CORP (LION) is 0 / 10.